Vimarsana
Biggest News Aggregation in the World

Page 11 - Briggs Morrison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Briggs Morrison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Briggs Morrison Today - Breaking & Trending Today

Money on the Move: Auron, Frontera, Immunocore and More Reel in New Funds - Vimarsana News

Money on the Move: Auron, Frontera, Immunocore and More Reel in New Funds

Auron Therapeutics reels in $48 million to identify novel AI-based cancer targets, Frontera scoops up $160 million for AAV gene therapy and tech manufacturing and MMI scores $75 million for robotic microsurgery.

Arvinas (NASDAQ:ARVN) Stock Price Up 6.8% - Vimarsana News

Arvinas (NASDAQ:ARVN) Stock Price Up 6.8%

Arvinas, Inc. (NASDAQ:ARVN – Get Rating)’s share price rose 6.8% during trading on Wednesday . The company traded as high as $38.55 and last traded at $38.45. Approximately 3,358 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 473,004 shares. The stock had previously closed at $36.01. ARVN […]

Arvinas (NASDAQ:ARVN) Sets New 52-Week Low at $37.07 - Vimarsana News

Arvinas (NASDAQ:ARVN) Sets New 52-Week Low at $37.07

Arvinas, Inc. (NASDAQ:ARVN – Get Rating)’s share price reached a new 52-week low on Monday . The company traded as low as $37.07 and last traded at $37.07, with a volume of 3206 shares. The stock had previously closed at $40.13. A number of analysts have recently weighed in on the stock. Stifel Europe dropped […]

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Rating of "Hold" by Brokerages - Vimarsana News

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Rating of "Hold" by Brokerages

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) have been given a consensus rating of “Hold” by the six analysts that are covering the company, Marketbeat reports. Two analysts have rated the stock with a sell rating, one has given a hold rating and two have assigned a buy rating to the company. The […]

Analysts Anticipate Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Will Announce Earnings of -$0.69 Per Share - Vimarsana News

Analysts Anticipate Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Will Announce Earnings of -$0.69 Per Share

Wall Street analysts expect that Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) will post earnings of ($0.69) per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Syndax Pharmaceuticals’ earnings, with estimates ranging from ($0.74) to ($0.65). Syndax Pharmaceuticals reported earnings per share of ($0.44) during the same quarter last […]